levamisole has been researched along with Bladder Cancer in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (94.44) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catalona, WJ; Kadmon, D; Ratliff, TL; Shapiro, A | 1 |
| Lamm, DL; Reichert, DF | 1 |
| Akaza, H; Crabtree, WN; Matheny, RB; Soloway, MS | 1 |
| Dimopoulos, C; Giannopoulos, A; Kioupkiolis, G; Lykourinas, M | 1 |
| Kato, J; Ohtaguro, K; Tsujimura, S; Ueda, K | 1 |
| Lindner, A; Madgar, I; Many, M; Moroz, C; Twig, S | 1 |
| Anichkov, NM; Lomakina, II; Zubzhitskiĭ, IuN | 1 |
| Schulman, CC; Zlotta, AR | 1 |
| Gutterman, JU; Hersh, EM; Mavligit, GM | 1 |
| Baron, B; Dekernion, J; Kaufman, JJ; Skinner, DG; Smith, RB | 1 |
| deKernion, JB; Fahey, JL; Nathanson, SD; Portaro, JK; Zamfirescu, PL | 1 |
| deKernion, J; Kaufman, JJ; Lincoln, B; Skinner, DG; Smith, RB | 1 |
| Christophersen, IS; Lundbeck, F | 1 |
| Hozumi, T; Iwaguchi, T; Kitagawa, H; Ozawa, H | 1 |
| Akaza, H; Niijima, T; Umeda, T; Yokoyama, H | 1 |
| Horváth, J; Romics, I | 1 |
| Csontai, A; Fehér, J; Horváth, J; Romics, I | 1 |
| Morales, A; Pang, AS | 1 |
3 review(s) available for levamisole and Bladder Cancer
| Article | Year |
|---|---|
Immunotherapy of superficial bladder cancer.
Topics: BCG Vaccine; Clinical Trials as Topic; Double-Blind Method; Hemocyanins; Humans; Immunotherapy; Interferons; Levamisole; Picibanil; Poly I-C; Prospective Studies; Random Allocation; Transfer Factor; Urinary Bladder Neoplasms | 1982 |
Biological response modifiers for the treatment of superficial bladder tumors.
Topics: Administration, Intravesical; Administration, Oral; Humans; Immunologic Factors; Levamisole; Neoplasm Staging; Urinary Bladder Neoplasms | 2000 |
BCG as adjuvant immunotherapy for neoplasia.
Topics: Animals; Antibody Formation; Antigens, Neoplasm; BCG Vaccine; Breast Neoplasms; Colonic Neoplasms; Disease Models, Animal; Head and Neck Neoplasms; Humans; Immunity, Cellular; Leukemia; Levamisole; Lung Neoplasms; Lymphoma; Macrophages; Melanoma; Mononuclear Phagocyte System; Neoplasms; T-Lymphocytes; Urinary Bladder Neoplasms | 1977 |
4 trial(s) available for levamisole and Bladder Cancer
| Article | Year |
|---|---|
Immunotherapy of superficial bladder cancer.
Topics: BCG Vaccine; Clinical Trials as Topic; Double-Blind Method; Hemocyanins; Humans; Immunotherapy; Interferons; Levamisole; Picibanil; Poly I-C; Prospective Studies; Random Allocation; Transfer Factor; Urinary Bladder Neoplasms | 1982 |
Levamisole in the treatment of non-invasive and invasive bladder cancer: a preliminary report.
Topics: Aged; Antigens, Neoplasm; Carcinoma, Transitional Cell; Chemotaxis, Leukocyte; Clinical Trials as Topic; Dinitrochlorobenzene; Double-Blind Method; Humans; Leukocyte Count; Levamisole; Monocytes; Placebos; Recurrence; Skin Tests; Urinary Bladder Neoplasms | 1978 |
Acute effects of orally administered levamisole on random monocyte motility and chemotaxis in man.
Topics: Administration, Oral; Adult; Aged; Carcinoma, Transitional Cell; Cell Movement; Chemotaxis, Leukocyte; Clinical Trials as Topic; Female; Humans; Lectins; Levamisole; Lymphocyte Activation; Male; Middle Aged; Monocytes; Urinary Bladder Neoplasms | 1978 |
Preliminary report of the use of levamisole in the treatment of bladder cancer.
Topics: Carcinoma, Transitional Cell; Chemotaxis, Leukocyte; Clinical Trials as Topic; Dinitrochlorobenzene; Double-Blind Method; Female; Humans; Levamisole; Male; Monocytes; Recurrence; Time Factors; Urinary Bladder Neoplasms | 1978 |
12 other study(ies) available for levamisole and Bladder Cancer
| Article | Year |
|---|---|
Long term protection in bladder cancer following intralesional immunotherapy.
Topics: Adjuvants, Immunologic; Animals; BCG Vaccine; Carcinoma, Transitional Cell; Cell Line; Evaluation Studies as Topic; Glycolipids; Immunization; Immunotherapy; Levamisole; Mice; Mice, Inbred C3H; Mycobacterium bovis; Neoplasm Recurrence, Local; Time Factors; Urinary Bladder Neoplasms | 1984 |
Chemoimmunotherapy of implanted murine bladder cancer.
Topics: Animals; Carcinoma, Transitional Cell; Drug Therapy, Combination; Female; Levamisole; Mice; Mice, Inbred C3H; Mitomycin; Mitomycins; Neoplasms, Experimental; Organ Size; Spleen; Time Factors; Urinary Bladder Neoplasms | 1983 |
The place of chemotherapy associated with active immunotherapy with levamisol in advanced bladder cancer.
Topics: Combined Modality Therapy; Doxorubicin; Fluorouracil; Humans; Immunotherapy; Levamisole; Urinary Bladder Neoplasms | 1984 |
[Treatment of tumors of the urinary bladder with so-called immunopotentiators].
Topics: Adjuvants, Immunologic; Aged; Antibiotics, Antineoplastic; Biological Products; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Female; Humans; Levamisole; Male; Middle Aged; Phytohemagglutinins; Picibanil; Prognosis; Proteoglycans; Skin Tests; Urinary Bladder Neoplasms | 1983 |
Disease-related lymphocyte cytotoxicity in rats bearing transitional cell carcinoma of bladder. Effect of immunomodulators.
Topics: Animals; Carcinoma, Transitional Cell; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Killer Cells, Natural; Levamisole; Lymphocytes; Male; Neoplasms, Experimental; Poly I-C; Rats; T-Lymphocytes; Urinary Bladder Neoplasms | 1982 |
[Experimental carcinogenesis in the urinary bladder against a background of Freund adjuvant and levamisole administration].
Topics: Animals; Antineoplastic Agents; Butylhydroxybutylnitrosamine; Cell Transformation, Neoplastic; Freund's Adjuvant; Levamisole; Male; Neoplasms, Experimental; Nitrosamines; Papilloma; Rats; Time Factors; Urinary Bladder Neoplasms | 1980 |
Phase II study of adriamycin, 5-fluorouracil, levamisole, and irradiation in carcinoma of the bladder.
Topics: Bone Marrow; Carcinoma, Transitional Cell; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Fluorouracil; Humans; Levamisole; Nausea; Remission, Spontaneous; Urinary Bladder Neoplasms | 1979 |
Anticancer activity of isomers of 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole.
Topics: Animals; Carcinoma; Drug Administration Schedule; Drug Therapy, Combination; Levamisole; Neoplasms, Experimental; Nitrosamines; Nitrosourea Compounds; Rats; Stereoisomerism; Tetramisole; Urinary Bladder Neoplasms | 1978 |
Restoration by levamisole of E-rosette formation and its abrogation by autochthonous serum from patients with bladder cancer.
Topics: Binding Sites; Cell Membrane; Erythrocytes; Female; Humans; Immunosuppression Therapy; Levamisole; Lymphocytes; Male; Middle Aged; Rosette Formation; Urinary Bladder Neoplasms | 1979 |
Study of cytotoxicity against adenovirally transformed cells in patients with tumours of the urinary tract.
Topics: Adenoviruses, Human; Carcinoma, Papillary; Cell Transformation, Viral; Cells, Cultured; Cytotoxicity, Immunologic; Humans; In Vitro Techniques; Levamisole; Male; Monocytes; Prostatic Neoplasms; Urinary Bladder Neoplasms | 1986 |
Effect of levamisol on cellular and humoral immune reactivity and on recurrences in patients with bladder papilloma.
Topics: Aged; Female; Humans; Immunoglobulin G; Immunotherapy; Leukocyte Count; Levamisole; Lymphocyte Activation; Male; Middle Aged; Neoplasm Recurrence, Local; Papilloma; Rosette Formation; Tuberculin Test; Urinary Bladder Neoplasms | 1985 |
Prophylaxis and therapy of an experimental bladder cancer with biological response modifiers.
Topics: Animals; BCG Vaccine; Female; Fluorenes; Immunotherapy; Levamisole; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Poly I-C; Tilorone; Urinary Bladder Neoplasms | 1986 |